MIRA INFORM REPORT

Report Date :

18.01.2008

IDENTIFICATION DETAILS

Name :	NEUTRO PHARMA (PRIVATE) LIMITED

Registered Office :	9.5 Km, Sheikhupura Road, Lahore

Country :	Pakistan

Date of Incorporation :	2002

Com. Reg. No.:	0044741

Legal Form :	Private Limited Company

Line of Business :	Manufacture & Marketing of Pharmaceutical & Neutraceutical Medicine

RATING & COMMENTS

MIRA’s Rating :

RATING		STATUS	PROPOSED CREDIT LINE
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory

Status :	Satisfactory

Payment Behaviour :	No Complaints

Litigation :	Clear

Business Name

NEUTRO PHARMA (PRIVATE) LIMITED

Full Address

Registered Address & Factory

9.5 Km, Sheikhupura Road, Lahore, Pakistan.

Tel

92 (42) 7915786, 7915787, 7915788, 7915789, 7915790

Fax

92 (42) 7915791

hraza@shoa.net

nppl@shoa.net

Short Description Of Business

Nature of Business	Manufacture & Marketing of Pharmaceutical & Neutraceutical Medicine.
Year Established	2002
Registration #	0044741

Branches

In Karachi & Rawalpindi

Auditors

M/s Arshad & Co.

(Chartered Accountants)

102-Nawab Plaza, 48-Main Shadman Market, Lahore, Pakistan

Legal Status

Subject Company was established as a Private Limited Company in 2002

Authorized Capital	Rs. 10,000,000 divided into 100,000 shares of Rs. 100/- Each
Issued & Paid up Capital	Rs. 10,000,000 divided into 100,000 shares of Rs.100/- each

Details of Directors

Names

Nationality

Address

Occupation

Designation

Mr. Hamid Raza

Mr. Amir Raza

Mrs. Sarwat Hamid

Pakistani

9.5 K.M., Sheikhupura Road, Lahore

Business

Chief Executive

Director

Shareholders

Names

No. of Shares

Mr. Hamid Raza

Mr. Amir Raza

Mrs. Sarwat Hamid

70,000

15,000

Associated Companies

Shaf Pharmaceuticals, Lahore, Pakistan.

Adnan Traders, Quetta, Pakistan.

Darex Pharma., Faisalabad, Pakistan.

Trade Suppliers (Local and Foreign)

(1) Prinsen B.V., Holland.

(2) Schills Food, Holland.

Dongkoo Pharmaceuticals Co., Ltd, Korea.

Dia Han Pharmaceuticals Co., Ltd, Korea.

Unimed Pharmaceuticals Incorporated, Korea.

Wakamoto Pharmaceuticals Co. Ltd, Japan.

Bouchara Recorditi, France.

I.C. Products, Switzerland.

Mass Pharma. (Pvt) Ltd., Pakistan.

P.D.H Pharmaceuticals (Pvt) Ltd., Pakistan.

Popular Chemical Works (Pvt) Ltd., Pakistan.

Xenon Pharmaceuticals (Pvt) Ltd., Pakistan.

Products

NEUTRACEUTICALS:

Setpoint Diet Starter Pack Low Calorie Diet For treatment of obesity (Beginners pack).

Setpoint Diet Low Calorie Diet For treatment of obesity

(Regular use pack).

Supplement-M Starter Pack Special Nutritional formula for pregnant women

Supplement-M Special nutritional formula for Lactating mothers.

Moducal High calorie balance diet for patients in hyper

catabolic state.

Glucotrol Therapeutic nutrition for Diabetics.

PHARMACEUTICALS:

Indrop-D Inj/Oral Cholecalciferol.

Neutrocyn Doxycycline.

Famodine 20 Famotidine 20 mg tabs.

Famodine 40 Famotidine 40 mg.

Newsadal Norfloxacin.

Kite Ketamine Inj.

Socin 1gm Ceftriaxone Sodium inj 1 gm.

Socin 500 mg Ceftriaxone Sodium inj 500 mg.

Socin 250 mg Ceftriaxone Sodium inj 250 mg.

Gynosept Disinfectant Solution for gynecological

Procedures.

Fermacidal Disinfectant solution for general

Procedures.

OTHERS:

Hico Vasoactive agent.

Leberplant Hepatoprotective and Hepatoregenerative

Agent with silimarin.

SERVICES:

Audiocassettes programs for obese patients to guide them for effective weight loss program.

Audiocassettes programs for pregnants to guide them for health pregnancy.

Audio program for

Modern concepts in selling

Personal grooming

Objection handling

Closing skills

4. Medical journal (In process).

Number of Employees

150

Annual Production Volume

The capacity and production of the company’s plant is indeterminable as it is multi-product and involves varying processes of manufacture.

Annual Sales Volume

Year	In Pak Rupees
2006	130,000,000/- (Estimated)

Distributors

40 distributors throughout the country.

Customers (Local)

Khyber Enterprises	Mardan
Hidayat Medicose	Mingora
Yousaf Zai Traders	Kohat
Friends Medicine Co.	Doaba
Naeem Enterprises	Peshawar
S.A.Traders	Gujranwala
Health Care Distributor	Gujrat
Farhan Pharma	Sialkot
Majeed Sons Medicine Co.	Bahawalnagar
Malik Enterprises	Multan
Fahad Pharma	D.G.Khan
Horizon Pharma/Syed Med Co	Layyah
Mian Pharma	Vehari
R. A. Traders	Bahawalpur
Khan Agencies	R.Y.Khan
Naeel-u-Shifa/Sakhawat Tdrs	Sargodha
Saad Medicine Co.	Mianwali
Ahbab Corporation	Faisalabad
Awais Marketing	Jhang
Zam Zam Medical Store	Sahiwal
Kohsar Distributors	Rawalpindi
Serwer	Rawalpindi
Nimra Farma ABT	Abbotabad
Sarwar Lahore	Lahore
Haroon Brothers	Sheikhupura
Nadeem Drug Agency	Kasur
Chishti Enterprises	D.I.Khan
Al-Noor Agency	Bannu
Zahoor Medical Store	Bhakkar
Hi Firm	Karachi
Farooq Traders	Karachi
Murshad Medicine Company	Sukkur
Sambara Drug House	Jacobabad
Saqib Traders	Larkana
Apex Drug Link	Hyderabad
Pharma City	Hyderabad
Neel Enterprises	Quetta

Bankers and their address

(1) MCB Bank Limited, Nila Gumbad Branch, Lahore, Pakistan.

(2) Union Bank, Shadman Market Branch, Lahore, Pakistan.

(3) Allied Bank, Temple Road Branch, Lahore, Pakistan.

Memberships

Pakistan Pharmaceutical Manufacturers Association.(PPMA)

Lahore Chamber of Commerce & Industry.(LCCI)

Foreign Exchange Rates

Currency	Unit	Pakistani Rupee
US Dollar	1	Rs. 62.50
UK Pound	1	Rs. 122.30
Euro	1	Rs. 92.40

Comments

Subject Company was established in 2002 and is engaged in manufacture & marketing of Pharmaceutical Products. Market reputation is good. Trade relations are reported as fair. The Company can be considered for normal business dealings at usual trade terms & conditions.

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
NR		In view of the lack of information, we have no basis upon which to recommend credit dealings	No Rating

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions